Search by Drug Name or NDC
NDC 70710-1543-08 ZALDYON 800 mg/1 Details
ZALDYON 800 mg/1
ZALDYON is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is MESALAMINE.
MedlinePlus Drug Summary
Mesalamine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Mesalamine is in a class of medications called anti-inflammatory agents. It works by stopping the body from producing a certain substance that may cause inflammation.
Related Packages: 70710-1543-08Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Mesalamine
Product Information
| NDC | 70710-1543 |
|---|---|
| Product ID | 70710-1543_dcbddcc0-3d6a-4c4e-817c-699e31171810 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | ZALDYON |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | mesalamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 800 |
| Active Ingredient Units | mg/1 |
| Substance Name | MESALAMINE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Aminosalicylate [EPC], Aminosalicylic Acids [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203286 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1543-08 (70710154308)
| NDC Package Code | 70710-1543-8 |
|---|---|
| Billing NDC | 70710154308 |
| Package | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (70710-1543-8) |
| Marketing Start Date | 2019-01-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |